Status:
COMPLETED
Obstetric Fecal Incontinence Treatment Registry
Lead Sponsor:
Hospital San Carlos, Madrid
Conditions:
Fecal Incontinence
Eligibility:
All Genders
16-84 years
Brief Summary
INTRODUCTION Anal Incontinence (AI) is a loose of voluntary control for bowel movements, with recurrent leaking of flatus, liquid or solid stools. AI is a frecuent pathology. Prevalence is similar am...
Detailed Description
MATERIAL AND METHODS PATIENTS AND METHOD A retrospective Cohort study was designed, based on a prospectively maintained database, including every consecutive patient operated on severe AI secondary t...
Eligibility Criteria
Inclusion
- Any person with kind of sphincteric lesion susceptible of surgical repair.
- Presenting with Anal Incontinence and severe impairment in quality of life.
- Unsatisfactory results after following a conservative treatment.
Exclusion
- Not exclusion criteria except non-fitting inclusion criteria.
Key Trial Info
Start Date :
December 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04727463
Start Date
December 16 2020
End Date
December 16 2020
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carlos Cerdán
Madrid, Spain